<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; AMF</title>
	<atom:link href="http://www.tapanray.in/tag/amf/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Self-made Barriers To Business Transparency Impacting Drug Access</title>
		<link>http://www.tapanray.in/self-made-barriers-to-business-transparency-impacting-drug-access/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=self-made-barriers-to-business-transparency-impacting-drug-access</link>
		<comments>http://www.tapanray.in/self-made-barriers-to-business-transparency-impacting-drug-access/#comments</comments>
		<pubDate>Mon, 05 Aug 2019 00:00:30 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[72nd]]></category>
		<category><![CDATA[AMF]]></category>
		<category><![CDATA[assembly]]></category>
		<category><![CDATA[Barriers]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Draft]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[foundation]]></category>
		<category><![CDATA[Geneva]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[IFPMA]]></category>
		<category><![CDATA[impact access]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Orginal]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[resolution]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[transparency]]></category>
		<category><![CDATA[WHA]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9655</guid>
		<description><![CDATA[A recently published book on pharma industry tried to expose the deceit behind many generic-drug manufacturing—and the consequent risks to global health. This publication is described as an ‘explosive narrative investigation of the generic drug boom that reveals fraud and life-threatening dangers &#8230; <a href="http://www.tapanray.in/self-made-barriers-to-business-transparency-impacting-drug-access/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/self-made-barriers-to-business-transparency-impacting-drug-access/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antimicrobial Resistance: A Recent Perspective</title>
		<link>http://www.tapanray.in/antimicrobial-resistance-a-recent-perspective/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=antimicrobial-resistance-a-recent-perspective</link>
		<comments>http://www.tapanray.in/antimicrobial-resistance-a-recent-perspective/#comments</comments>
		<pubDate>Mon, 19 Feb 2018 00:00:27 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[AMF]]></category>
		<category><![CDATA[AMR]]></category>
		<category><![CDATA[antibiotic]]></category>
		<category><![CDATA[antibiotics]]></category>
		<category><![CDATA[Antimicrobial]]></category>
		<category><![CDATA[chemists]]></category>
		<category><![CDATA[Davos]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[FDCs]]></category>
		<category><![CDATA[foundation]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[ICMR]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[initiatives]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[resistance]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[unapproved]]></category>
		<category><![CDATA[UNGA]]></category>
		<category><![CDATA[WEF]]></category>
		<category><![CDATA[World Economic Forum]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8798</guid>
		<description><![CDATA[On January 23, 2018, at the World Economic Forum in Davos, Switzerland – the first independent analysis of pharmaceutical industry efforts to tackle antibiotic drug resistance, was published by the Netherlands based Access to Medicine Foundation. The issue of Antimicrobial &#8230; <a href="http://www.tapanray.in/antimicrobial-resistance-a-recent-perspective/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/antimicrobial-resistance-a-recent-perspective/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
